Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines : A Correlation with the Differentiation Status
In acute myeloid leukemia (AML), a low level of reactive oxygen species (ROS) is associated with leukemic stem cell (LSC) quiescence, whereas a high level promotes blast proliferation. ROS homeostasis relies on a tightly-regulated balance between the antioxidant and oxidant systems. Among the oxidants, NADPH oxidases (NOX) generate ROS as a physiological function. Although it has been reported in AML initiation and development, the contribution of NOX to the ROS production in AML remains to be clarified. The aim of this study was to investigate the NOX expression and function in AML, and to examine the role of NOX in blast proliferation and differentiation. First, we interrogated the NOX expression in primary cells from public datasets, and investigated their association with prognostic markers. Next, we explored the NOX expression and activity in AML cell lines, and studied the impact of NOX knockdown on cell proliferation and differentiation. We found that NOX2 is ubiquitously expressed in AML blasts, and particularly in cells from the myelomonocytic (M4) and monocytic (M5) stages; however, it is less expressed in LSCs and in relapsed AML. This is consistent with an increased expression throughout normal hematopoietic differentiation, and is reflected in AML cell lines. Nevertheless, no endogenous NOX activity could be detected in the absence of PMA stimulation. Furthermore, CYBB knockdown, although hampering induced NOX2 activity, did not affect the proliferation and differentiation of THP-1 and HL-60 cells. In summary, our data suggest that NOX2 is a marker of AML blast differentiation, while AML cell lines lack any NOX2 endogenous activity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Antioxidants (Basel, Switzerland) - 10(2021), 3 vom: 23. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dakik, Hassan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 13.04.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/antiox10030498 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323626017 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323626017 | ||
| 003 | DE-627 | ||
| 005 | 20231225184602.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antiox10030498 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1078.xml |
| 035 | |a (DE-627)NLM323626017 | ||
| 035 | |a (NLM)33807114 | ||
| 035 | |a (PII)498 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dakik, Hassan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines |b A Correlation with the Differentiation Status |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.04.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a In acute myeloid leukemia (AML), a low level of reactive oxygen species (ROS) is associated with leukemic stem cell (LSC) quiescence, whereas a high level promotes blast proliferation. ROS homeostasis relies on a tightly-regulated balance between the antioxidant and oxidant systems. Among the oxidants, NADPH oxidases (NOX) generate ROS as a physiological function. Although it has been reported in AML initiation and development, the contribution of NOX to the ROS production in AML remains to be clarified. The aim of this study was to investigate the NOX expression and function in AML, and to examine the role of NOX in blast proliferation and differentiation. First, we interrogated the NOX expression in primary cells from public datasets, and investigated their association with prognostic markers. Next, we explored the NOX expression and activity in AML cell lines, and studied the impact of NOX knockdown on cell proliferation and differentiation. We found that NOX2 is ubiquitously expressed in AML blasts, and particularly in cells from the myelomonocytic (M4) and monocytic (M5) stages; however, it is less expressed in LSCs and in relapsed AML. This is consistent with an increased expression throughout normal hematopoietic differentiation, and is reflected in AML cell lines. Nevertheless, no endogenous NOX activity could be detected in the absence of PMA stimulation. Furthermore, CYBB knockdown, although hampering induced NOX2 activity, did not affect the proliferation and differentiation of THP-1 and HL-60 cells. In summary, our data suggest that NOX2 is a marker of AML blast differentiation, while AML cell lines lack any NOX2 endogenous activity | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AML | |
| 650 | 4 | |a NADPH oxidase | |
| 650 | 4 | |a leukemia | |
| 650 | 4 | |a transcriptomics | |
| 700 | 1 | |a El Dor, Maya |e verfasserin |4 aut | |
| 700 | 1 | |a Leclerc, Joan |e verfasserin |4 aut | |
| 700 | 1 | |a Kouzi, Farah |e verfasserin |4 aut | |
| 700 | 1 | |a Nehme, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Deynoux, Margaux |e verfasserin |4 aut | |
| 700 | 1 | |a Debeissat, Christelle |e verfasserin |4 aut | |
| 700 | 1 | |a Khamis, Georges |e verfasserin |4 aut | |
| 700 | 1 | |a Ducrocq, Elfi |e verfasserin |4 aut | |
| 700 | 1 | |a Ibrik, Aida |e verfasserin |4 aut | |
| 700 | 1 | |a Stasia, Marie-José |e verfasserin |4 aut | |
| 700 | 1 | |a Raad, Houssam |e verfasserin |4 aut | |
| 700 | 1 | |a Rezvani, Hamid Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Gouilleux, Fabrice |e verfasserin |4 aut | |
| 700 | 1 | |a Zibara, Kazem |e verfasserin |4 aut | |
| 700 | 1 | |a Herault, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Mazurier, Frédéric |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antioxidants (Basel, Switzerland) |d 2012 |g 10(2021), 3 vom: 23. März |w (DE-627)NLM256601127 |x 2076-3921 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:3 |g day:23 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/antiox10030498 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 3 |b 23 |c 03 | ||